Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis: A Randomized, Double-Blind, Multicenter Study : Journal of the American Society of Nephrology

Journal Logo

Human Mineral Metabolism and Bone Disease

Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis: A Randomized, Double-Blind, Multicenter Study

Lindberg, Jill S.*; Culleton, Bruce; Wong, Gordon; Borah, Michael F.§; Clark, Roderick V.; Shapiro, Warren B.; Roger, Simon D.**; Husserl, Fred E.*; Klassen, Preston S.††; Guo, Matthew D.††; Albizem, Moetaz B.††; Coburn, Jack W.‡‡,a

Author Information
Journal of the American Society of Nephrology 16(3):p 800-807, March 2005. | DOI: 10.1681/ASN.2004060512

Abstract

Copyright © 2005 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid